---

title: "Risk Factors for Severe Post-COVID Condition in Children, Adolescents, and Young Adults"
tags:
- ‚ûï 2025-12-25
- üß™ Biomarker
- ‚≠ê Landmark
created: '2025-12-02'
published: '2025-12-02'

---


<details>
<summary>Donath et al. (2025)</summary>

- **Authors:** Quirin Donath, Matthias Haegele MD, Daniela Schindler PhD, Tiziana Welzhofer MD, Catharina Christa MD, Annika Grabbe MD, Ariane Leone MD, Clara Ilhan MD, Carola Weidmann MSc, Maria Eberhartinger MA, Sara Bechtold MSc, Nicola Bursch MSc, Hedwig Wolf, Hannah Hieber, Laura-Carlotta Peo, Lara A. Bucka, Silvia Stojanov MD PhD, Cordula Warlitz MD, Martin Alberer MD PhD, Katrin Gerrer MSc, Anna Hausruckinger PhD, Kirstin Mittelstrass PhD, Clemens-Martin Wendtner MD PhD, Manuela A. Hoechstetter MD PhD, Armin Gr√ºbl MD, Nicole Toepfner MD PhD, Rafael Pricoco MD, Carmen Scheibenbogen MD PhD, Lorenz L. Mihatsch MD MSc, Uta Behrends MD PhD.
- **Institutes:** Munich Chronic Fatigue Center for Young People (MCFC), Technical University of Munich (TUM), Munich, Germany; German Center for Infection Research (DZIF), Munich, Germany; Ludwig-Maximilians University (LMU), Munich, Germany; University Hospital Carl Gustav Carus, Dresden, Germany; Charit√© ‚Äì Universit√§tsmedizin Berlin, Berlin, Germany.
- **Publisher:** medRxiv
- **Link:** [DOI](https://doi.org/10.1101/2025.12.01.25341171)

</details>


## Summary

This research is significant for the ME/CFS community as it provides clear evidence that the illness is not a random outcome but often follows a predictable pattern of severe acute symptoms in young people. By establishing that factors like "brain fog" and dizziness during the initial infection are major risk markers, the study supports the need for early medical recognition rather than a "wait and see" approach. These findings may help patients and families advocate for earlier support and could eventually lead to targeted trials for those most likely to remain chronically ill.

## What was researched?

This study aimed to identify specific factors during the initial (acute) phase of a COVID-19 infection that could predict which children and young people are most likely to develop severe long-term illness. Specifically, the researchers looked for indicators that lead to severe Post-COVID Condition (PCC) and the development of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

## Why was it researched?

While Post-COVID Condition is recognized as a significant health burden in younger populations, there has been a lack of evidence regarding which early symptoms signal a high risk for severe outcomes. Identifying these predictors early is essential for clinicians to provide timely interventions and appropriate care pathways, especially for those at risk of the most debilitating forms of the disease.

## How was it researched?

The researchers conducted an observational registry study at a specialized pediatric hospital in Munich, Germany, involving 120 participants aged 7 to 25 years who were diagnosed with PCC. They utilized standardized assessment tools, including the novel Munich Long COVID Symptom Questionnaire (MLCSQ), to track symptom progression from the acute infection through the chronic phase. Severity was determined using several established scales for fatigue, autonomic dysfunction, and physical function, while ME/CFS was diagnosed according to established clinical criteria.

## What has been found?

The study found that a high number of symptoms during the initial infection (12 or more), female sex, and specific acute symptoms like orthostatic intolerance (dizziness upon standing) and concentration difficulties were strong predictors of severe long-term illness. Specifically, 24% of the participants were diagnosed with ME/CFS, all of whom belonged to the "severe" group characterized by high symptom complexity and poor physical function. A threshold of 12 or more acute symptoms was identified as a highly specific indicator for those likely to require intensive monitoring.

## Discussion

The authors acknowledge that the study's monocentric design (conducted at a single hospital) and its nature as a registry study may limit the generalizability of the findings to the broader population. However, they emphasize that this is the first systematic investigation to successfully link acute-phase symptoms to severe PCC and ME/CFS in children and young people, providing a valuable framework for risk stratification.

## Conclusion & Future Work

The authors conclude that the complexity and type of symptoms present during the very first weeks of infection serve as early warning signs for severe chronic illness and ME/CFS. They suggest that future research and clinical management should focus on integrating ME/CFS expertise into standard pediatric care for those identified as high-risk early on.
